TY - JOUR
T1 - Novel OTOG Variants and Clinical Features of Hearing Loss in a Large Japanese Cohort
AU - Arai, Yasuhiro
AU - Nishio, Shin Ya
AU - Goto, Shinichi
AU - Kobayashi, Yumiko
AU - Honkura, Yohei
AU - Ganaha, Akira
AU - Ishikawa, Kotaro
AU - Oka, Shin Ichiro
AU - Futagawa, Hiroshi
AU - Okami, Mayuri
AU - Takada, Fumio
AU - Nagai, Kyoko
AU - Esaki, Tomoko
AU - Okano, Takayuki
AU - Ohta, Yumi
AU - Masuda, Shin
AU - Egusa, Kentaro
AU - Teraoka, Masato
AU - Sugahara, Kazuma
AU - Usami, Shin Ichi
N1 - Publisher Copyright:
© 2025 by the authors.
PY - 2025/1
Y1 - 2025/1
N2 - Background/Objectives: The OTOG gene is responsible for autosomal recessive non-syndromic sensorineural hearing loss and is assigned as DFNB18B. To date, 44 causative OTOG variants have been reported to cause non-syndromic hearing loss. However, the detailed clinical features for OTOG-associated hearing loss remain unclear. Methods: In this study, we analyzed 7065 patients with non-syndromic hearing loss (mean age 26.4 ± 22.9 years, 2988 male, 3855 female, and 222 without gender information) using massively parallel DNA sequencing for 158 target deafness genes. We identified the patients with biallelic OTOG variants and summarized the clinical characteristics. Results: Among the 7065 patients, we identified 14 possibly disease-causing OTOG variants in 26 probands, with 13 of the 14 variants regarded as novel. Patients with OTOG-associated hearing loss mostly showed congenital or childhood-onset hearing loss. They were considered to show non-progressive, mild-to-moderate hearing loss. There were no symptoms that accompanied the hearing loss in OTOG-associated hearing loss patients. Conclusions: We confirmed non-progressive, mild-to-moderate hearing loss as the clinical characteristics of OTOG-associated hearing loss. These findings will contribute to a better understanding of the clinical features of OTOG-associated HL and will be useful in clinical practice.
AB - Background/Objectives: The OTOG gene is responsible for autosomal recessive non-syndromic sensorineural hearing loss and is assigned as DFNB18B. To date, 44 causative OTOG variants have been reported to cause non-syndromic hearing loss. However, the detailed clinical features for OTOG-associated hearing loss remain unclear. Methods: In this study, we analyzed 7065 patients with non-syndromic hearing loss (mean age 26.4 ± 22.9 years, 2988 male, 3855 female, and 222 without gender information) using massively parallel DNA sequencing for 158 target deafness genes. We identified the patients with biallelic OTOG variants and summarized the clinical characteristics. Results: Among the 7065 patients, we identified 14 possibly disease-causing OTOG variants in 26 probands, with 13 of the 14 variants regarded as novel. Patients with OTOG-associated hearing loss mostly showed congenital or childhood-onset hearing loss. They were considered to show non-progressive, mild-to-moderate hearing loss. There were no symptoms that accompanied the hearing loss in OTOG-associated hearing loss patients. Conclusions: We confirmed non-progressive, mild-to-moderate hearing loss as the clinical characteristics of OTOG-associated hearing loss. These findings will contribute to a better understanding of the clinical features of OTOG-associated HL and will be useful in clinical practice.
KW - congenital hearing loss
KW - DFNB18B
KW - mild-to moderate hearing loss
KW - non-progressive hearing loss
KW - non-syndromic hearing loss
KW - OTOG
KW - otogelin
UR - http://www.scopus.com/inward/record.url?scp=85215797978&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85215797978&partnerID=8YFLogxK
U2 - 10.3390/genes16010060
DO - 10.3390/genes16010060
M3 - Article
C2 - 39858607
AN - SCOPUS:85215797978
SN - 2073-4425
VL - 16
JO - Genes
JF - Genes
IS - 1
M1 - 60
ER -